Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro - Concepedia

Concepedia

Publication | Closed Access

Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro

21

Citations

37

References

2012

Year

Carolin C. Schneider, Sabine Kartarius, Mathias Montenarh, Andrzej Orzeszko, Zygmunt Kazimierczuk

Bioorganic & Medicinal Chemistry

MedicinePharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyCk2 Inhibitory ActivityDrug Discovery

References

	Year	Citations

Page 1